January/February 2013 - Volume 36 - Issue 1
pp: 1-35
Subscribe to eTOC

Safety and Pharmacology of a Single Intravenous Dose of Ponezumab in Subjects With Mild-to-Moderate Alzheimer Disease: A Phase I, Randomized, Placebo-Controlled, Double-Blind,...

Landen, Jaren W.; Zhao, Qinying; Cohen, Sharon; More

Clinical Neuropharmacology . 36(1):14-23, January/February 2013.